Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin for post-operative high cardiac output hypotension after cardiac surgery
ACTRN12613001194752Phase 4Not yet recruiting
- Sponsor
- Austin Health
- Start
- Jun 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative hypotension and Vasoplegia comparing Terlipressin with Placebo (2 arms). Primary endpoint: Mean arterial blood pressure. Planned start Jun 2018; status: not yet recruiting.
02
Drugs
terlipressin
03
Conditions
postoperative hypotensionVasoplegia
Beyond the preview
Go deeper on ACTRN12613001194752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001194752.